SD

Sreedhar Donkena

Director Director DIN 09192178
DIN 09192178 First appointment Jun 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sreedhar Donkena

Data last updated:

Sreedhar Donkena was a Director at Credas Impex Private Limited (2021–2024) and Managing Director at Credas Labs Private Limited (2021). The companies operate in Pharma.

DIN 09192178
Primary Designation Director
Industry Pharma
First Appointment 02 Jun 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Credas Impex Private Limited U24239TG2021PTC157249
Director23 Nov 20212021Active
Credas Labs Private Limited U24100TG2021PTC151978
Managing Director02 Jun 20212021₹1.16 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Credas Impex Private Limited
Credas Labs Private Limited
Premium access

Shareholding and investment profile for Sreedhar Donkena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreedhar Donkena

Sreedhar Donkena was first appointed on 02 Jun 2021 as Managing Director at Credas Labs Private Limited.

Sreedhar Donkena held 2 earlier board appointments: Credas Impex Private Limited (Director, 23 Nov 2021 to 07 May 2024); Credas Labs Private Limited (Managing Director, 02 Jun 2021 to 24 Sep 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available